Navigation Links
Haemonetics Announces Launch of Faster Plasma Collection Protocol
Date:6/16/2008

BRAINTREE, Ma., June 16 /PRNewswire-FirstCall/ -- Haemonetics Corporation announced today at the annual meeting of the Plasma Protein Therapeutics Association the launch of a plasma collection software for its PCS(R)2 plasma collection system that reduces plasma donation time by 20%.

Stephen Swenson, General Manager of Global Plasma for Haemonetics, said, "This new software system, with its faster donation times, combined with our recently launched information technology platforms that automate center operations, are significant enhancements to our product offerings. These systems help our plasma customers to better leverage their plasma collection infrastructure by increasing donor throughput and also provide the donor with a more positive donation experience."

"As the global leader in blood management solutions, we are pleased to be continually strengthening our product suite with products, information technology platforms, and business services for blood collectors and hospitals to improve patient outcomes," he added.

The PCS2 software was 510(k) cleared by the U.S. Food and Drug Administration on May 28, 2008. The software can be used with existing PCS2 devices so no device replacement or additional operator training is required. The product will be launched in limited market release, with full market release expected by year end.

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com .

Contact:

Julie Fallon

Tel. (781) 356-9517

Alt. Tel. (617) 320-2401


'/>"/>
SOURCE Haemonetics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Haemonetics and Octapharma AG Announce Plasma Collection Technology Contract
2. Haemonetics(R) Appoints Peter Allen as Chief Marketing Officer
3. Haemonetics Becomes Preferred Provider of Plasma Collection Products to Octapharma Europe
4. Haemonetics Announces New Subsidiary, Haemonetics Software Solutions
5. Meritage Pharma, Inc. Announces Company Formation and $22.5M Series A Financing
6. Angiotech announces market launch of Quill(TM) SRS MONODERM(TM)
7. Exelixis Announces June 19 Webcast of Presentation at the William Blair 28th Annual Growth Stock Conference
8. Villa St. Benedict Announces New Web Site
9. BioNeutral Announces a BREAKTHROUGH in the Fight Against Bioterrorism
10. Indevus Announces Management Changes
11. Chindex International, Inc. Announces Fiscal 2008 Year End and Fourth Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" ... in China, today announced its financial results for the fourth ... Quarter 2016 Financial Highlights Total sales ... RMB terms, or increased by 13.6% in USD terms to ... 2015. Gross profit increased by 13.3% to ...
(Date:2/23/2017)... 23, 2017 ... per share data, unaudited)Three Months Ended December 31,Twelve Months ... $         ...   89026%Aldurazyme Net Product Revenue ... Net Product Revenue  756025%297303(2)%Vimizim Net ...
(Date:2/23/2017)... Feb. 23, 2017  In Atlanta, it seems everyone has ... culture intertwine to create an expressive and dynamic community unlike ... energy and contribute to it. With their ... Fairies seeks to carry on that tradition with a ... Atlanta salon is the newest of 13 nationwide ...
(Date:2/23/2017)... ... February 23, 2017 , ... Baltimore ... multiple immunoassay-based threat detection technologies by researchers from the Pacific National Northwest ... detection technology was found to have the best level of detection (LOD) ...
Breaking Biology Technology:
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
(Date:2/2/2017)... , Feb. 2, 2017   TapImmune, ... clinical-stage immuno-oncology company specializing in the development of ... the treatment of cancer and metastatic disease, announced ... and GMP manufacturing of a second clinical lot ... targeting folate receptor alpha. The manufactured vaccine product ...
(Date:1/30/2017)...   Invitae Corporation (NYSE: NVTA ... today announced that it will report its fourth quarter ... on Monday, February 13, 2017, and Invitae,s management team ... p.m. Eastern / 1:45 p.m. Pacific. ... financial results, guidance, and recent developments and will spend ...
Breaking Biology News(10 mins):